Conference Information

Welcome Message

Welcome to Cardiology 2024, the highly anticipated 7th International Conference on Cardiology, taking place on January 11-12, 2024, in the vibrant city of Dubai, UAE.

Cardiology Conferences 2024 serves as the premier platform for researchers, scholars, students, esteemed society members, industry professionals, and academics to converge and engage in discussions on various facets of Cardiology.

We extend a warm invitation to experts from diverse backgrounds, be it academia, business, or industry, to enrich Cardiology Conferences 2024 by sharing your research abstracts, papers, and posters from across the globe. This conference aims to foster global interdisciplinary collaboration and knowledge exchange among technologists.

Dubai, with its captivating backdrop, promises an exceptional blend of social and scientific experiences. We are thrilled to welcome you to Dubai and look forward to your participation.

Join us in Dubai for Cardiology 2024, where innovative ideas and collaborations will thrive!

Best regards,
The Organizing Committee
Cardiology Conferences 2024

Important Deadlines and Venue

Please make note of these important deadlines for the Cardiology Conferences 2024:

Extended Abstract Submission Deadline: October 30, 2023.
Final Paper Submission Deadline: October 30, 2023.
Deadline for Final Phase Early Bird Registration: October 30, 2023.
You will receive notifications of Abstract Acceptance/Rejection within 1-2 days.
The Conference is scheduled for January 11-12, 2023, in Dubai, UAE.
All deadlines are set according to the Midnight-11:59 pm London Time Zone.

Consider forming a group with a minimum of 5 members to enjoy a 35% discount on the total registration fee.

Don't miss out on the exciting perks available during the early bird registration, valid until the second phase of early bird registration.

Tracks and Sessions

Track: 01 Cardiology

Cardiology could also be a discipline of medication that focuses on disorders with the heart and different elements of the vascular system. Innate heart defects, artery illness, failure, controller disorder, and electrophysiology area unit all embowered throughout this field.

Cardiologists, a subspecialty of medicine, area unit doctors World Health Organization specialize in this branch of medication. Medicine cardiologists area unit cardiology-focused physicians. Cardiothoracic surgeons, usually remarked as organ surgeons, area unit general surgery specialists World Health Organization specialize in organ surgery.

Congenital heart defects
Coronary artery sickness
Heart failure
Valvular cardiopathy
Electrophysiology

Related Journals:- European heart journal, Journal of the American College of Cardiology, British Journal of Cardiology, Journal of Cardiovascular Electrophysiology, Journal of Cardiovascular Electrophysiology, Journal of the American College of Cardiology: Heart Failure, Circulation, American Journal of Cardiovascular Drugs, European journal of cardiovascular prevention and rehabilitation, European Heart Journal-Cardiovascular Imaging, The Journal of Thoracic and Cardiovascular Surgery

Tracks: 02 Heart Rhythm and Arrhythmias

Technology to assist patients with cardiopathy disorders management their diseases is growing at such a quick rate that ideas that appeared not possible solely a couple of years agone square measure already a reality. Leadless pacemakers, hypodermic implantable cardioverter defibrillators, hypodermic implantable loop recorders, and strategies to form ablation simpler square measure among the innovative technology unaccustomed the market or in clinical testing.

Tachycardia
Bradycardia
Supraventricular arrhythmias
Ventricular arrhythmias
Bradyarrhythmia’s

Track: 03 Heart Diseases

Calcium build-up throughout a significant artery outside the heart might indicate a future attack or stroke. In step with researchers, individuals with abdominal arteria calcification (AAC) have a 2 to fourfold exaggerated risk of a future vessel incident. The study conjointly discovered that the a lot of atomic number 20 within the vessel wall, the upper the prospect of future vessel events, which persons with AAC and chronic excretory organ malady were at a fair higher risk than those while not AAC.

Calcium will build up within the vessel wall and harden the arteries, obstructing blood flow or inflicting plaque rupture, each of that area unit common cause of heart attacks and strokes.

Poor diet, a inactive style, smoking, and genetic science area unit all factors that contribute to blood vessel calcification.

Coronary Artery illness
Heart Arrhythmias
Heart Failure
Heart Valve illness
Pericardial illness
Cardiomyopathy
Congenital heart condition

Track: 04 Hypertension

Hypertension is also a serious risk issue for cardiopathy and stroke. Around a 3rd of individuals with high blood pressure are currently unknown, and half of people who are known aren't taking antihypertensive drugs. The World Health Organization (WHO) estimates that prime blood pressure kills a minimum of 9 million people worldwide every year, either directly or indirectly.
Our goal is to spotlight recent advances in high blood pressure clinical and basic analysis, yet on discuss future ways within the discipline's development and building.

Hypertension-overview
Hypertensive heart disease
Primary and secondary high blood pressure
High blood pressure treatments
High blood pressure medications

Related Journals: European heart journal, Journal of the American College of Cardiology, British Journal of Cardiology, Journal of Cardiovascular Electrophysiology, Journal of Cardiovascular Electrophysiology, Journal of the American College of Cardiology: Heart Failure, Circulation, American Journal of Cardiovascular Drugs, European journal of cardiovascular prevention and rehabilitation, European Heart Journal-Cardiovascular Imaging, The Journal of Thoracic and Cardiovascular Surgery

Track: 05 Heart Failure

Heart failure (HF) is a serious cardiovascular ailment due to its increased prevalence, significant morbidity, high mortality, and rapidly rising healthcare costs. All throughout the world, the number of people who have heart failure is increasing. Significant improvements have been made in the definition, diagnostic procedures, and management of heart failure during the past 40 years. The classification of HF risk is being improved by the use of biomarkers, imaging, and genetic testing.

Newly developed HF medications and technology are now frequently used in clinical settings. A left ventricular assist device or a heart transplant are two examples of the last treatments for end-stage heart failure that are rapidly developing.

Atrial Fibrillation
Device Therapy
Chronic Heart Failure
Acute Heart Failure
Acute Cardiac Care
Cardiovascular dieases

Track: 06 Cardiac Imaging

As a consequence of significant technology advancements, evolved cardiac imaging today performs both diagnostic and prognostic functions. Patients with heart failure must have routine follow-up Cardiac imaging, such as echocardiography, or more advanced Cardiac imaging, such as stress imaging.

Patients with heart failure benefit from interventional treatments and imaging-guided therapy. The goal of this study is to present a thorough overview of the most modern imaging techniques for the detection and management of heart failure.

Artificial Intelligence
CT Imaging
CT Calcium Scoring Now Part of Guidelines
Important Cardiology Articles
New Cardiac CT scanner Technology
Advances in Spectral Imaging
Special Sessions for EP and Structural Heart

Track: 07 Myocardial Infarction

Research on novel therapies, mechanical and pharmacological techniques, and repair/regenerative cellular therapy to treat irreversible cardiovascular diseases such as myocardial infarction has advanced. New cellular kinds are being studied in cellular treatment research. Although cell therapy's therapeutic benefits are currently limited, clinical trial outcomes are encouraging.

Advances in stem cell paracrine activity, the utilisation of growth factors, miRNA, and new biomaterials are assisting in this advancement. These treatments should become more frequent in clinical practise in the near future.

Percutaneous coronary intervention
Coronary artery bypass grafting
primary coronary event, such as plaque rupture
A problem of oxygen supply and demand
Sudden cardiac death

Related Journals: European heart journal, Journal of the American College of Cardiology, British Journal of Cardiology, Journal of Cardiovascular Electrophysiology, Journal of Cardiovascular Electrophysiology, Journal of the American College of Cardiology: Heart Failure, Circulation, American Journal of Cardiovascular Drugs, European journal of cardiovascular prevention and rehabilitation, European Heart Journal-Cardiovascular Imaging, The Journal of Thoracic and Cardiovascular Surgery

Track: 08 Pulmonary heart diseases

Pulmonary hypertension is difficult to detect in its early stages since it is seldom identified through a routine physical examination. Even after the disease has advanced, the signs and symptoms are similar to those of other heart and lung disorders.

Significant advancements in therapeutic options for pulmonary arterial hypertension (PAH) have recently occurred, resulting in improved patient outcomes. Our objective is to present the most recent advancements in the management of pulmonary heart disorders.

Dyspnea
Pulmonary Embolism
Hypercapnia
Obstructive Sleep Apnea
Chronic Obstructive Pulmonary Disease
Hypoxemia
Heart Failure

Track: 09 Coronary artery disease

Coronary artery disease (CAD) is the leading cause of mortality worldwide. While coronary artery disease symptoms and indications are recognised in late stages of the illness, the majority of affected individuals do not exhibit any symptoms or signs for decades as the disease progresses until the first symptom, which is generally a "sudden" heart attack, manifests.

After decades of development, some of these atheromatous plaques may rupture, decreasing the blood flow to the heart muscle (along with the activation of the blood clotting system). The condition is the main cause of sudden death in both men and women over the age of 20, as well as the top cause of death overall.

People with this degree of coronary artery disease frequently have had one or more myocardial infarctions (heart attacks), and they may be exhibiting signs and symptoms of chronic coronary ischemia, such is sudden pulmonary edoema and resting angina.

Obstructive coronary artery disease
Non-obstructive coronary artery disease
Coronary micro vascular disease
Coronary Artery Bypass Surgery
High blood pressure

Track: 10 Cardiovascular Diseases

The greatest cause of mortality globally is cardiovascular disease (CVD), which is expected to take the lives of 17.9 million people annually. Cardiovascular disease CVDs include conditions including coronary heart disease, cerebrovascular disease, rheumatic heart disease, and various issues with the heart and blood vessels. More than four out of every five CVD deaths result from heart attacks and strokes, with one-third of these deaths happening before the age of 70.

A variety of laboratory tests and imaging examinations are used to diagnose cardiovascular disorders. The medical and family histories of the patient, risk factors, physical examination, and synchronisation of these findings with the results of tests and procedures are the most important aspects of diagnosis.

Abnormal heart rhythms, or arrhythmias
Congenital heart disease
Deep vein thrombosis
Pulmonary embolism
Heart muscle disease

Track: 11 Women and Heart Diseases

Cardiac disease is the leading cause of mortality among women. Cardiovascular disease has different effects on women as compared to men.. Men, for example, have more heart attacks than women, but women are more likely to die from heart attacks than men. Women had a higher risk of bleeding after percutaneous coronary interventions (PCI) using femoral artery access. Women are likewise more likely to experience drug-induced cardiac arrhythmias.

The completed research have helped to generate guiding papers for medication and device development for men and women, as well as a better understanding of cardiovascular disease in women.

Anxiety and Heart Disease
Assessing Cardiovascular Risk with C-Reactive Protein
Depression and Heart Disease
Menopause and the Cardiovascular System
Peripartum Cardiomyopathy
Diabetes and Heart Disease in Women
New Imaging Techniques: Risks and Benefits
Vitamin D and the Heart

Track: 12 Cardiac surgery and Transplantation

Every day, enhancements within the field of surgical operation area unit created. Cardiac surgery is turning into easier and safer, and recovery is turning into quicker and fewer painful, because of advances in technology. New and artistic techniques for minimally invasive operations, newest technologies, and clinical trials area unit all serving to advance the science of surgical operation in Beaumont, reducing recovery periods and creating surgical operation less painful for patients.

With the introduction of newer immunological disorder medicine and procedures that will doubtless end in tolerance, the longer term of heart transplantation appears bright. Improved information of acute and chronic rejection pathways through basic science investigations supports abundant of this improvement in heart transplant treatment. Customized drugs are going to be a vicinity of the longer term, with genetic science and molecular analysis dictating specific treatment for best results.

Coronary artery bypass affixation
Heart valve repair or replacement
Insertion of a pacemaker or Associate in Nursing implantable cardioverter electronic device
Maze surgery
Aneurysm repair
Heart transplant
Insertion of a bodily cavity assist device (VAD) or total implant (TAH)

Track: 13 Echocardiography

For the assessment of patients with controller Cardiac disease, diagnostic procedure is that the most popular imaging modality. Advances in diagnostic procedure could have a major impact on the assessment and treatment of people with controller Cardiac diesease. This review can highlight this analysis on enhancements during this patient population, together with three-dimensional diagnostic procedure, strain imaging, intracardiac diagnostic procedure, and fusion imaging.

Cardiomyopathies
Diseases of the arteria
Transesophageal diagnostic procedure
Stress echo diagnostic procedure
Computed picturing

Track: 14 Clinical Cardiology

Clinical medicine could be a specialty of drugs that focuses on the designation and treatment of vessel disorders. Interventional medicine, internal organ electrophysiology, diagnostic procedure, and nuclear medicine area unit all common specialties for cardiologists. Once it involves internal organ diseases, every of those specialties has its own set of techniques.

This session can have a gaint impact on internal organ analysis within the future. Medicine is that the study of heart illnesss and disorders such arteria coronaria disease and symptom coronary failure. nonheritable heart defects, arteria coronaria illness, coronary failure, tube heart condition, and electrophysiology area unit all lined among clinical medicine.

Acute Coronary Syndromes
Heart Failure and Cardiomyopathies
Geriatric medicine
Arrhythmias and Clinical EP
Invasive vessel X-ray photography and Intervention
Valvular Cardiac Diseases

Track: 15 Cardiology clinical case reports

By providing their necessary clinical samples of late incidence, Cardiology case reports offer a perfect assemblage for all cardiologists. Clinicians, students, and paramedical workers members gain important expertise through learning Cardiology cases.

Rare medical reports and conditions uncovered victimisation newest examination techniques area unit supported. What is more, learning diagnostic procedures from medical cases and symptom interpretation is very important for coaching and raising the processes used within the clinical field.

Case reports on Cardiac surgery
Case reports on Vascular heart disease
Case reports on Hypertension and Healthcare
Case reports on Cardiac and Cardiovascular research
Case reports on Paediatric Cardiology
Case reports on Heart diagnosis
Case reports on heart disease & Failure
Case reports on Atherosclerosis
Case reports on Heart devices

Track: 16 Interventional Cardiology

Interventional cardiology could also be a rapidly expanding specialty. This expansion is thanks to advancements in existing technology, the creation of the latest technologies, and thus the extension of patient selection criteria.

Recent randomized studies examining the efficacy of revascularization or medical treatment in stable ischemic heart disease, the treatment of acute coronary syndromes, emerging interventional devices, adjunctive pharmacotherapy, and intravascular imaging and physiology guidance have advanced the evidence-based knowledge in interventional cardiology significantly.

Ischemic heart diseases
Angiogram
Angioplasty
Disorders of heart valves
Valvuloplasty

Track: 17 Paediatric Cardiology

Paediatric cardiology has made considerable strides in the past year. Several clinical trials and the publication of expert opinions in various subspecialties have shown to be extremely helpful in improving the diagnosis and treatment of cardiovascular disease in children.

Paediatric cardiology is the study of cardiovascular disease in children who are still growing and developing. To offer complete patient care, paediatric cardiologists need to be well-versed in both general paediatrics and heart disease.

Fetal cardiology
Arrhythmias
Paediatric cardiac imaging
Multicentre heart failure
Quality Improvement

Track: 18 Cardiovascular Pharmacology

Cardiovascular pharmacotherapy is still a very active field. The goal of this study is to outline recent key breakthroughs in cardiovascular pharmacotherapy, with an emphasis on a recently approved medicine for heart failure treatment.

Despite all advancements in pharmacological and therapeutic therapy, heart failure continues to be a major source of morbidity and mortality across the world. Numerous novel treatment approaches, such as cell transplantation, gene transfer or therapy, and the use of cytokines or other tiny molecules, have been studied to treat heart failure.

Cotransporter
Endothelial Progenitor Cell
Blood Pressure
Actinobacteria
Leporidae

Track: 19 Future Cardiology

Future cardiovascular care will be revolutionised by artificial intelligence, digital health technology, and mobile devices as a means of preventing and treating heart disease.

The sound, beat, pace, structure, and function of the heart are all closely watched in order to keep it as healthy as possible for as long as possible. An army of digital health technology has lately allied with conventional cardiology preventative methods to help avoid stroke, heart attack, heart failure, or any other cardiovascular risk. Artificial intelligence, digital twins, and tiny sensors may be able to assist them in the future. Let's see what the cardiology of the future could contain!

Innovative imaging and device technologies
Surgical and interventional approaches
Cardiovascular disease's molecular basis
New diagnostic methods, screening, and patient classification are all being explored.
Cardiology personalised medication
Therapeutic overviews showcasing the best treatment options and future possibilities
Evidence from the real world and outcomes research

Track: 20 Diagnosis & Treatment of Heart Disease

Several drugs are used to treat heart disease. Understanding their drugs, reading the labels, and being aware of any potential adverse effects are essential for people with heart disease and those who provide care for them.

A medical diagnosis is made using a patient's and family history, physical examination results, interviews with the patient and their families, clinical laboratory and radiographic test results, and other factors. Cardiovascular disease can be identified via Cardiac imaging methods, Cardiac surgery, electrophysiology, angiography, radiography, and other methods. Hospital care is necessary after a diagnosis of heart disease.

Echocardiogram
Cardiac Catheterization
Electrophysiology Test
CT Heart Scan
Myocardial Biopsy
Pericardiocentesis

Track: 21 Stem cell and Regenerative Biology

The heart's limited ability to regenerate itself is what leads to cardiac failure and death. Similar to how your body would repair a wound, damaged cardiac cells are tough to recover from. Studying how the heart grows in infants and later adults is a logical next step for scientists who are interested in producing and repairing cardiac cells.

Additionally, researchers are examining how cardiac cells created from stem cells repair damaged hearts and whether they may be utilised to address issues with the heart muscle.

Adult stem cells
Pluripotent stem cells
Cardiac Stem-Ness
Applications of PSCs in cardiovascular research
Translational potential of PSC
Pluripotent stem cells in first human trials

Market Analysis

Market Analysis:

In the year 2022, the global interventional cardiology sector recorded a value of approximately $13,760.84 million. Forecasts indicate that this market is poised for growth, with an expected increase to approximately $23,813.91 million by the year 2029, driven by a compounded annual growth rate (CAGR) of 8.2%.

Cardiology devices market size, share, and trends by application, product, and region, with segment forecasts for 2020-2029

The cardiology devices market has undergone significant evolution from 2019 to 2029, reflecting a dynamic landscape characterized by shifting trends and innovations. This comprehensive analysis encompasses a range of applications, products (including accessories and surgical devices), and regions, providing valuable insights for stakeholders. Throughout this decade, the market has seen steady growth, driven by an increasing prevalence of cardiovascular diseases worldwide. Notably, advancements in surgical devices and accessories have paved the way for more precise interventions, while innovations like minimally invasive procedures and personalized treatment plans have gained prominence. Geographically, various regions have witnessed unique trends, with North America and Europe being early adopters of cutting-edge cardiology devices, while the Asia-Pacific region has shown substantial growth potential, driven by improving healthcare infrastructure. As we progress further into the decade, the cardiology devices market is expected to continue its expansion, fuelled by technological advancements, growing healthcare awareness, and the imperative need to combat cardiovascular diseases effectively.

About Venue

Dubai seamlessly combines tradition and modernity, offering a rich cultural heritage alongside its iconic deserts, beaches, and lavish structures. With a diverse population of over 200 nationalities, it's a welcoming and cosmopolitan destination. Dubai's excellent infrastructure, spanning trade, transport, tourism, industry, and finance, attracts international investors. Visitors can explore traditional souks, upscale malls, enjoy desert adventures, and marvel at architectural wonders like the Burj Khalifa. Whether you're seeking luxury, gourmet dining, shopping, or technological marvels, Dubai has it all, making it a truly unique city where old-world charm meets innovation.

Visa Support

Need visa support for Cardiology Conferences 2024 in Dubai, UAE? We've got you covered!

To assist with your visa application, we provide essential documents including an Official Invitation Letter, Abstract Acceptance Letter, Payment Receipt, and Visa Covering Letter.

Remember: